{"id":126427,"date":"2021-08-05T09:00:00","date_gmt":"2021-08-05T09:00:00","guid":{"rendered":"https:\/\/icrowdnewswire.com\/?p=2898365"},"modified":"2021-08-05T09:00:00","modified_gmt":"2021-08-05T09:00:00","slug":"covid-19-vaccine-and-therapeutics-pipeline-analysis-key-companies-working-in-domain-includes-novavax-capricor-imv-abbvie-amgen-synairgen-maxwell-biosciences-veru-galera-sorrento-xenothera","status":"publish","type":"post","link":"https:\/\/ipsnews.net\/business\/2021\/08\/05\/covid-19-vaccine-and-therapeutics-pipeline-analysis-key-companies-working-in-domain-includes-novavax-capricor-imv-abbvie-amgen-synairgen-maxwell-biosciences-veru-galera-sorrento-xenothera\/","title":{"rendered":"COVID-19 Vaccine and Therapeutics Pipeline Analysis | Key Companies Working in Domain Includes Novavax, Capricor, Imv, AbbVie, Amgen, Synairgen, Maxwell Biosciences, Veru, Galera, Sorrento, Xenothera, and Many Others"},"content":{"rendered":"<p><img decoding=\"async\" width=\"300\" height=\"300\" src=\"https:\/\/icrowdnewswire.com\/wp-content\/uploads\/2021\/05\/5353-Delveinsight.png\" class=\"webfeedsFeaturedVisual wp-post-image\" alt=\"\" loading=\"lazy\" style=\"display: block; margin-bottom: 5px; clear:both;max-width: 100%;\" link_thumbnail=\"\" \/><\/p>\n<p><img decoding=\"async\" loading=\"lazy\" src=\"https:\/\/beta-kiosk.icrowdnewswire.com\/assets\/source\/users\/delveinsight\/COVID-19-CoronaVirus-Pipeline-therapies-.jpg?1628137680266\" alt=\"COVID-19-CoronaVirus-Pipeline-therapies-\" width=\"684\" height=\"356\" \/><\/p>\n<p><span style=\"font-weight: 400;\">DelveInsight&rsquo;s <\/span><strong>COVID-19 Pipeline Insights<\/strong><span style=\"font-weight: 400;\"> report provides a comprehensive outlook of the pipeline therapies that are in different clinical and pre-clinical stages of development, their launch, and how the market is expected to transform in the aftermath across the COVID-19 domain.<\/span><\/p>\n<p><span style=\"font-weight: 400;\">The <\/span><a href=\"https:\/\/www.delveinsight.com\/report-store\/covid-19-pipeline-insight?utm_source=Icrowd&amp;utm_medium=pressrelease&amp;utm_campaign=rpr\"><strong>COVID-19 Pipeline Analysis<\/strong><\/a><span style=\"font-weight: 400;\"> report offers an in-depth analysis of the therapeutics landscape by development stage, product type, route of administration, molecule type, and MOA for COVID-19 emerging therapies.&nbsp;<\/span><span style=\"font-weight: 400;\">The pipeline report lays down the business opportunities, threats, prospective collaborations, strong competitors, and growth strategies.&nbsp;<\/span><\/p>\n<p><strong>Some of the key highlights from the COVID-19 Pipeline report:<\/strong><\/p>\n<ul>\n<li style=\"font-weight: 400;\"><span style=\"font-weight: 400;\">The COVID-19 continues to possess a serious public health issue worldwide, however, more than 8 vaccines have been approved for emergency use over the past few months with several therapies in the pipeline, while few of the vaccine trials have been abandoned after insufficient results.<\/span><\/li>\n<li style=\"font-weight: 400;\"><span style=\"font-weight: 400;\">At present the clinical management includes infection prevention and control measures. Sometimes, supportive care such as supplemental oxygen and mechanical ventilatory support is also required in some serious cases.<\/span><\/li>\n<li style=\"font-weight: 400;\"><span style=\"font-weight: 400;\">Currently, the three main <\/span><strong>types of COVID-19 vaccines <\/strong><span style=\"font-weight: 400;\">namely mRNA Vaccine, protein subunit vaccines, and vector vaccines are available in the market. Global pharma and biotech companies are actively exploring new potential vaccines with several of the emerging vaccines in the advanced stages.<\/span><\/li>\n<li style=\"font-weight: 400;\"><span style=\"font-weight: 400;\">At present, more than <\/span><strong>150+ key companies<\/strong><span style=\"font-weight: 400;\"> are involved in the development of <\/span><a href=\"https:\/\/www.delveinsight.com\/report-store\/covid-19-pipeline-insight?utm_source=Icrowd&amp;utm_medium=pressrelease&amp;utm_campaign=rpr\"><strong>therapies for the COVID-19<\/strong><\/a><span style=\"font-weight: 400;\"> which includes <\/span><strong>Novavax, Capricor Therapeutics, Imv Inc., AbbVie, Amgen, Synairgen, Maxwell Biosciences, <\/strong> <strong>Veru Inc., Galera Therapeutics, Sorrento Therapeutics, Xenothera, RSV Therapeutics, <\/strong><span style=\"font-weight: 400;\">and many others.&nbsp;<\/span><\/li>\n<li style=\"font-weight: 400;\"><span style=\"font-weight: 400;\">Some of the <\/span><strong>COVID-19 emerging therapies<\/strong><span style=\"font-weight: 400;\"> expected to enter the market include <\/span><strong>MXB-009, DPX COVID 19, CAP-1002, GC4419, Otezla, SNG001, PSC 04, ABBV-47D11, XC221, XAV-19, <\/strong><span style=\"font-weight: 400;\">and several others.&nbsp;<\/span><\/li>\n<li style=\"font-weight: 400;\"><span style=\"font-weight: 400;\">Among the emerging therapies <\/span><strong>ZyCoV-D, VLA2001, ARCoV, NVX-CoV2373, Corbevax, Vidprevtyn, and Nanocovax <\/strong><span style=\"font-weight: 400;\">are in the most advanced stage (Phase III) stages of vaccine development.<\/span><\/li>\n<\/ul>\n<p><span style=\"font-weight: 400;\">Request for Sample @ <\/span><a href=\"https:\/\/www.delveinsight.com\/sample-request\/covid-19-pipeline-insight?utm_source=Icrowd&amp;utm_medium=pressrelease&amp;utm_campaign=rpr\"><strong>COVID-19 Pipeline Insights and Outlook<\/strong><\/a><\/p>\n<p><a href=\"https:\/\/www.delveinsight.com\/report-store\/covid-19-pipeline-insight?utm_source=Icrowd&amp;utm_medium=pressrelease&amp;utm_campaign=rpr\"><strong>COVID-19 Pipeline Therapies<\/strong><\/a><\/p>\n<ul>\n<li style=\"font-weight: 400;\"><span style=\"font-weight: 400;\">MXB-009<\/span><\/li>\n<li style=\"font-weight: 400;\"><span style=\"font-weight: 400;\">DPX COVID 19<\/span><\/li>\n<li style=\"font-weight: 400;\"><span style=\"font-weight: 400;\">CAP-1002<\/span><\/li>\n<li style=\"font-weight: 400;\"><span style=\"font-weight: 400;\">GC4419<\/span><\/li>\n<li style=\"font-weight: 400;\"><span style=\"font-weight: 400;\">Otezla<\/span><\/li>\n<li style=\"font-weight: 400;\"><span style=\"font-weight: 400;\">SNG001<\/span><\/li>\n<li style=\"font-weight: 400;\"><span style=\"font-weight: 400;\">PSC 04<\/span><\/li>\n<li style=\"font-weight: 400;\"><span style=\"font-weight: 400;\">CPI-006<\/span><\/li>\n<li style=\"font-weight: 400;\"><span style=\"font-weight: 400;\">Bucillamine<\/span><\/li>\n<li style=\"font-weight: 400;\"><span style=\"font-weight: 400;\">Losmapimod<\/span><\/li>\n<li style=\"font-weight: 400;\"><span style=\"font-weight: 400;\">ABBV-47D11<\/span><\/li>\n<\/ul>\n<p><strong>And many more<\/strong><\/p>\n<p><span style=\"font-weight: 400;\">The List of Emerging therapies is not exhaustive, the complete list will be provided in the final report, visit to know more @ <\/span><a href=\"https:\/\/www.delveinsight.com\/sample-request\/covid-19-pipeline-insight?utm_source=Icrowd&amp;utm_medium=pressrelease&amp;utm_campaign=rpr\"><strong>COVID-19 Therapeutics and Drugs Pipeline<\/strong><\/a><\/p>\n<p><a href=\"https:\/\/www.delveinsight.com\/report-store\/covid-19-pipeline-insight?utm_source=Icrowd&amp;utm_medium=pressrelease&amp;utm_campaign=rpr\"><strong>Key Companies in the COVID-19 Therapeutics Landscape<\/strong><\/a><strong>:<\/strong><\/p>\n<ul>\n<li style=\"font-weight: 400;\"><span style=\"font-weight: 400;\">Capricor Therapeutics<\/span><\/li>\n<li style=\"font-weight: 400;\"><span style=\"font-weight: 400;\">Imv Inc.<\/span><\/li>\n<li style=\"font-weight: 400;\"><span style=\"font-weight: 400;\">Kinarus<\/span><\/li>\n<li style=\"font-weight: 400;\"><span style=\"font-weight: 400;\">Veru Inc.<\/span><\/li>\n<li style=\"font-weight: 400;\"><span style=\"font-weight: 400;\">Novavax<\/span><\/li>\n<li style=\"font-weight: 400;\"><span style=\"font-weight: 400;\">AbbVie<\/span><\/li>\n<li style=\"font-weight: 400;\"><span style=\"font-weight: 400;\">Amgen<\/span><\/li>\n<li style=\"font-weight: 400;\"><span style=\"font-weight: 400;\">Synairgen Research<\/span><\/li>\n<li style=\"font-weight: 400;\"><span style=\"font-weight: 400;\">Xenothera<\/span><\/li>\n<li style=\"font-weight: 400;\"><span style=\"font-weight: 400;\">Zydus Cadila<\/span><\/li>\n<li style=\"font-weight: 400;\"><span style=\"font-weight: 400;\">RSV Therapeutics<\/span><\/li>\n<li style=\"font-weight: 400;\"><span style=\"font-weight: 400;\">Maxwell Biosciences<\/span><\/li>\n<li style=\"font-weight: 400;\"><span style=\"font-weight: 400;\">Galera Therapeutics<\/span><\/li>\n<li style=\"font-weight: 400;\"><span style=\"font-weight: 400;\">Sorrento Therapeutics<\/span><\/li>\n<li style=\"font-weight: 400;\"><span style=\"font-weight: 400;\">Corvus Pharmaceuticals<\/span><\/li>\n<li style=\"font-weight: 400;\"><span style=\"font-weight: 400;\">Fulcrum Therapeutics<\/span><\/li>\n<li style=\"font-weight: 400;\"><span style=\"font-weight: 400;\">Revive Therapeutics<\/span><\/li>\n<\/ul>\n<p><span style=\"font-weight: 400;\">And many others.<\/span><\/p>\n<p><a href=\"https:\/\/www.delveinsight.com\/report-store\/covid-19-pipeline-insight?utm_source=Icrowd&amp;utm_medium=pressrelease&amp;utm_campaign=rpr\"><strong>COVID-19 Pipeline Therapeutics Assessment<\/strong><\/a><\/p>\n<p><strong>By Product Type<\/strong><\/p>\n<ul>\n<li><span style=\"font-weight: 400;\">Monotherapy<\/span><\/li>\n<li><span style=\"font-weight: 400;\">Combination Therapy<\/span><\/li>\n<\/ul>\n<p><strong>By Stage<\/strong><\/p>\n<ul>\n<li><span style=\"font-weight: 400;\">Discovery&nbsp;<\/span><\/li>\n<li><span style=\"font-weight: 400;\">Pre-clinical<\/span><\/li>\n<li><span style=\"font-weight: 400;\">Phase I<\/span><\/li>\n<li><span style=\"font-weight: 400;\">Phase II<\/span><\/li>\n<li><span style=\"font-weight: 400;\">Phase III<\/span><\/li>\n<li><span style=\"font-weight: 400;\">Pre-registration&nbsp;<\/span><\/li>\n<\/ul>\n<p><strong>By Route of Administration<\/strong><\/p>\n<ul>\n<li>Oral<\/li>\n<li>Intravenous<\/li>\n<li><span style=\"font-weight: 400;\">Inhalation<\/span><\/li>\n<li><span style=\"font-weight: 400;\">Sub-cutaneous<\/span><\/li>\n<\/ul>\n<p><strong>By Molecule Type<\/strong><\/p>\n<ul>\n<li><span style=\"font-weight: 400;\">Small Molecule&nbsp;<\/span><\/li>\n<li><span style=\"font-weight: 400;\">Gene Therapy<\/span><\/li>\n<li><span style=\"font-weight: 400;\">Stem Cell Therapy&nbsp;<\/span><\/li>\n<\/ul>\n<p><strong>Targets:<\/strong><\/p>\n<ul>\n<li><span style=\"font-weight: 400;\">Interferon beta-1a<\/span><\/li>\n<li><span style=\"font-weight: 400;\">P38 mitogen-activated protein kinase<\/span><\/li>\n<li><span style=\"font-weight: 400;\">Type 4 cyclic nucleotide phosphodiesterase<\/span><\/li>\n<li><span style=\"font-weight: 400;\">Superoxide dismutase<\/span><\/li>\n<li><span style=\"font-weight: 400;\">Viral envelope protein<\/span><\/li>\n<\/ul>\n<p><strong>By Mechanism of Action<\/strong><\/p>\n<ul>\n<li><span style=\"font-weight: 400;\">Interferon-beta 1a replacements<\/span><\/li>\n<li><span style=\"font-weight: 400;\">P38 mitogen-activated protein kinase inhibitors<\/span><\/li>\n<li><span style=\"font-weight: 400;\">Cell replacements<\/span><\/li>\n<li><span style=\"font-weight: 400;\">Type 4 cyclic nucleotide phosphodiesterase inhibitors<\/span><\/li>\n<li><span style=\"font-weight: 400;\">Virus internalization inhibitors<\/span><\/li>\n<li><span style=\"font-weight: 400;\">Immunostimulants<\/span><\/li>\n<li><span style=\"font-weight: 400;\">Antioxidants<\/span><\/li>\n<li><span style=\"font-weight: 400;\">Viral envelope protein inhibitors<\/span><\/li>\n<li><span style=\"font-weight: 400;\">Angiotensin type 2 receptor agonists<\/span><\/li>\n<\/ul>\n<p>Got queries? Reach out for more information @ <a href=\"https:\/\/www.delveinsight.com\/sample-request\/covid-19-pipeline-insight?utm_source=Icrowd&amp;utm_medium=pressrelease&amp;utm_campaign=rpr\"><strong>COVID-19 Drug Pipeline Assessment<\/strong><\/a><strong>&nbsp;<\/strong><\/p>\n<p><strong>Scope of the Report<\/strong><\/p>\n<ul>\n<li style=\"font-weight: 400;\"><strong>Coverage: <\/strong><span style=\"font-weight: 400;\">Global<\/span><\/li>\n<li style=\"font-weight: 400;\"><strong>Key Market Players: <\/strong><span style=\"font-weight: 400;\">Novavax, Zydus Cadila, Capricor Therapeutics, Imv Inc., AbbVie, Amgen, Synairgen, Maxwell Biosciences, Kinarus, Galera Therapeutics, Sorrento Therapeutics, Xenothera, RSV Therapeutics, and many others.&nbsp;<\/span><\/li>\n<li style=\"font-weight: 400;\"><strong>Key Pipeline Therapies: <\/strong><span style=\"font-weight: 400;\">MXB-009, DPX COVID 19, CAP-1002, GC4419, Otezla, SNG001, PSC 04, ABBV-47D11, XC221, XAV-19, and several others.&nbsp;<\/span><\/li>\n<\/ul>\n<p><strong>Table of Content&nbsp;<\/strong><\/p>\n<table>\n<tbody>\n<tr>\n<td>\n<p><span style=\"font-weight: 400;\">1<\/span><\/p>\n<\/td>\n<td>\n<p><span style=\"font-weight: 400;\">Report Introduction<\/span><\/p>\n<\/td>\n<\/tr>\n<tr>\n<td>\n<p><span style=\"font-weight: 400;\">2<\/span><\/p>\n<\/td>\n<td>\n<p><span style=\"font-weight: 400;\">COVID-19&nbsp;<\/span><\/p>\n<\/td>\n<\/tr>\n<tr>\n<td>\n<p><span style=\"font-weight: 400;\">3<\/span><\/p>\n<\/td>\n<td>\n<p><span style=\"font-weight: 400;\">COVID-19 Current Treatment Patterns<\/span><\/p>\n<\/td>\n<\/tr>\n<tr>\n<td>\n<p><span style=\"font-weight: 400;\">4<\/span><\/p>\n<\/td>\n<td>\n<p><span style=\"font-weight: 400;\">COVID-19 &#8211; DelveInsight&#8217;s Analytical Perspective<\/span><\/p>\n<\/td>\n<\/tr>\n<tr>\n<td>\n<p><span style=\"font-weight: 400;\">5<\/span><\/p>\n<\/td>\n<td>\n<p><span style=\"font-weight: 400;\">Therapeutic Assessment<\/span><\/p>\n<\/td>\n<\/tr>\n<tr>\n<td>\n<p><span style=\"font-weight: 400;\">6<\/span><\/p>\n<\/td>\n<td>\n<p><span style=\"font-weight: 400;\">COVID-19 Late Stage Products (Phase-III)<\/span><\/p>\n<\/td>\n<\/tr>\n<tr>\n<td>\n<p><span style=\"font-weight: 400;\">7<\/span><\/p>\n<\/td>\n<td>\n<p><span style=\"font-weight: 400;\">COVID-19 Mid Stage Products (Phase-II)<\/span><\/p>\n<\/td>\n<\/tr>\n<tr>\n<td>\n<p><span style=\"font-weight: 400;\">8<\/span><\/p>\n<\/td>\n<td>\n<p><span style=\"font-weight: 400;\">Early Stage COVID-19 Products (Phase-I)<\/span><\/p>\n<\/td>\n<\/tr>\n<tr>\n<td>\n<p><span style=\"font-weight: 400;\">9<\/span><\/p>\n<\/td>\n<td>\n<p><span style=\"font-weight: 400;\">COVID-19 Pre-clinical Products and Discovery Stage Products<\/span><\/p>\n<\/td>\n<\/tr>\n<tr>\n<td>\n<p><span style=\"font-weight: 400;\">10<\/span><\/p>\n<\/td>\n<td>\n<p><span style=\"font-weight: 400;\">Inactive Products<\/span><\/p>\n<\/td>\n<\/tr>\n<tr>\n<td>\n<p><span style=\"font-weight: 400;\">11<\/span><\/p>\n<\/td>\n<td>\n<p><span style=\"font-weight: 400;\">Dormant Products<\/span><\/p>\n<\/td>\n<\/tr>\n<tr>\n<td>\n<p><span style=\"font-weight: 400;\">12<\/span><\/p>\n<\/td>\n<td>\n<p><span style=\"font-weight: 400;\">COVID-19 Discontinued Products<\/span><\/p>\n<\/td>\n<\/tr>\n<tr>\n<td>\n<p><span style=\"font-weight: 400;\">13<\/span><\/p>\n<\/td>\n<td>\n<p><span style=\"font-weight: 400;\">COVID-19 Product Profiles<\/span><\/p>\n<\/td>\n<\/tr>\n<tr>\n<td>\n<p><span style=\"font-weight: 400;\">14<\/span><\/p>\n<\/td>\n<td>\n<p><span style=\"font-weight: 400;\">COVID-19 Key Companies<\/span><\/p>\n<\/td>\n<\/tr>\n<tr>\n<td>\n<p><span style=\"font-weight: 400;\">15<\/span><\/p>\n<\/td>\n<td>\n<p><span style=\"font-weight: 400;\">COVID-19 Key Products<\/span><\/p>\n<\/td>\n<\/tr>\n<tr>\n<td>\n<p><span style=\"font-weight: 400;\">16<\/span><\/p>\n<\/td>\n<td>\n<p><span style=\"font-weight: 400;\">Dormant and Discontinued Products<\/span><\/p>\n<\/td>\n<\/tr>\n<tr>\n<td>\n<p><span style=\"font-weight: 400;\">17<\/span><\/p>\n<\/td>\n<td>\n<p><span style=\"font-weight: 400;\">COVID-19 Unmet Needs<\/span><\/p>\n<\/td>\n<\/tr>\n<tr>\n<td>\n<p><span style=\"font-weight: 400;\">18<\/span><\/p>\n<\/td>\n<td>\n<p><span style=\"font-weight: 400;\">COVID-19 Future Perspectives<\/span><\/p>\n<\/td>\n<\/tr>\n<tr>\n<td>\n<p><span style=\"font-weight: 400;\">19<\/span><\/p>\n<\/td>\n<td>\n<p><span style=\"font-weight: 400;\">COVID-19 Analyst Review<\/span><\/p>\n<\/td>\n<\/tr>\n<tr>\n<td>\n<p><span style=\"font-weight: 400;\">20<\/span><\/p>\n<\/td>\n<td>\n<p><span style=\"font-weight: 400;\">Appendix<\/span><\/p>\n<\/td>\n<\/tr>\n<tr>\n<td>\n<p><span style=\"font-weight: 400;\">21<\/span><\/p>\n<\/td>\n<td>\n<p><span style=\"font-weight: 400;\"> Report Methodology<\/span><\/p>\n<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p><span style=\"font-weight: 400;\">Know more of what&rsquo;s covered in the <\/span><a href=\"https:\/\/www.delveinsight.com\/sample-request\/covid-19-pipeline-insight?utm_source=Icrowd&amp;utm_medium=pressrelease&amp;utm_campaign=rpr\"><strong>COVID-19 Pipeline Assessment<\/strong><\/a><span style=\"font-weight: 400;\"> report<\/span><\/p>\n<p><strong>Key Questions Answered in the COVID-19 Report<\/strong><\/p>\n<ul>\n<li style=\"font-weight: 400;\"><span style=\"font-weight: 400;\">What are the current options for COVID-19 treatment?<\/span><\/li>\n<li style=\"font-weight: 400;\"><span style=\"font-weight: 400;\">How many companies are developing therapies for the treatment of COVID-19?&nbsp;<\/span><\/li>\n<li style=\"font-weight: 400;\"><span style=\"font-weight: 400;\">What are the principal therapies developed by these companies in the industry?<\/span><\/li>\n<li style=\"font-weight: 400;\"><span style=\"font-weight: 400;\">How many therapies are developed by each company for the treatment of COVID-19?<\/span><\/li>\n<li style=\"font-weight: 400;\"><span style=\"font-weight: 400;\">How many COVID-19 emerging therapies are in early-stage, mid-stage, and late stage of development for the treatment of COVID-19?<\/span><\/li>\n<li style=\"font-weight: 400;\"><span style=\"font-weight: 400;\">Out of total pipeline products, how many therapies are given as a monotherapy and in combination with other therapies?&nbsp;<\/span><\/li>\n<li style=\"font-weight: 400;\"><span style=\"font-weight: 400;\">What are the key collaborations (Industry-Industry, Industry-Academia), Mergers and acquisitions, and major licensing activities that will impact the COVID-19 market?&nbsp;<\/span><\/li>\n<\/ul>\n<p><span style=\"font-weight: 400;\">Request for a Webex demo @ <\/span><a href=\"https:\/\/www.delveinsight.com\/sample-request\/covid-19-pipeline-insight?utm_source=Icrowd&amp;utm_medium=pressrelease&amp;utm_campaign=rpr\"><strong>COVID-19 Drug Pipeline<\/strong><\/a><span style=\"font-weight: 400;\"> and get a walk-through of our report&nbsp;<\/span><\/p>\n<p><strong>Latest Reports<br \/><\/strong><strong><a href=\"https:\/\/www.delveinsight.com\/report-store\/covid-19-novel-coronavirus-19-therapeutic-pipeline-vaccines-diagnostics-competitive-landscape?utm_source=Icrowd&amp;utm_medium=pressrelease&amp;utm_campaign=rpr\">COVID 19 (Novel Coronavirus 19) Therapeutic Pipeline, Vaccines, and Diagnostics Competitive Landscape<\/a><br \/><\/strong><span style=\"font-weight: 400;\">DelveInsight&rsquo;s report on &ldquo;COVID 19 (Novel Coronavirus 19) Therapeutic Pipeline, Vaccines, and Diagnostics Competitive Landscape&rdquo; covers a detailed analysis of companies working for the development of drugs and vaccines as well as diagnostics companies are working on developing test kits. The report also proffers a solid foundation to advance further research and analysis into the COVID 19 covering morbidity and mortality.<\/span><\/p>\n<p><a href=\"https:\/\/www.delveinsight.com\/report-store\/global-messenger-rna-market\"><strong>mRNA Vaccines and Therapeutics Market<\/strong><\/a><br \/><span style=\"font-weight: 400;\">DelveInsight&rsquo;s &lsquo;Global Messenger RNA (mRNA) based Vaccines and Therapeutics Market Insights, Epidemiology, and Market Forecast 2030&rsquo; report deliver an in-depth understanding of the mRNA-based Vaccines and Therapeutics, along with its historical and forecasted epidemiology and market trends in North America, Europe, Asia, and ROW (rest of the world).<\/span><\/p>\n<p><a href=\"https:\/\/www.delveinsight.com\/report-store\/blastic-plasmacytoid-dendritic-cell-neoplasm-bpdcn-market\"><strong>Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN) Market<\/strong><\/a><br \/><span style=\"font-weight: 400;\">DelveInsight&#8217;s &#8220;Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN) Market Insights, Epidemiology, and Market Forecast 2030&#8221; report delivers an in-depth understanding of the disease, historical and forecasted epidemiology as well as the Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN) market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.<\/span><\/p>\n<p><a href=\"https:\/\/www.delveinsight.com\/report-store\/anti-hypertension-market\"><strong>Anti-hypertension Market<\/strong><\/a><br \/><span style=\"font-weight: 400;\">DelveInsight&#8217;s &#8220;Anti-hypertension Market Insights, Epidemiology, and Market Forecast 2030&#8221; report delivers an in-depth understanding of the historical and forecasted epidemiology as well as the Anti-hypertension market size and shares analysis in the 7MM (i.e the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan).<\/span><\/p>\n<p><a href=\"https:\/\/www.delveinsight.com\/report-store\/acute-pyelonephritis-market\"><strong>Acute Pyelonephritis Market<\/strong><\/a><br \/><span style=\"font-weight: 400;\">DelveInsight&#8217;s &#8220;Acute Pyelonephritis Market Insights, Epidemiology, and Market Forecast 2030&#8221; report delivers an in-depth understanding of the historical and forecasted epidemiology as well as the Acute Pyelonephritis market size and shares analysis in the 7MM (i.e the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan).<\/span><\/p>\n<p><a href=\"https:\/\/www.delveinsight.com\/report-store\/corneal-endothelial-dystrophy-market\"><strong>Corneal Endothelial Dystrophy Market<\/strong><\/a><br \/><span style=\"font-weight: 400;\">DelveInsight&#8217;s &#8220;Corneal Endothelial Dystrophy Market Insights, Epidemiology, and Market Forecast 2030&#8221; report delivers an in-depth understanding of the historical and forecasted epidemiology as well as the Corneal Endothelial Dystrophy market size and shares analysis in the 7MM (i.e the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan).<\/span><\/p>\n<p><strong><a href=\"https:\/\/www.delveinsight.com\/report-store\/type-2-diabetes-market\">Type 2 Diabetes Market<\/a><br \/><\/strong><span style=\"font-weight: 400;\">DelveInsight&#8217;s &#8220;Type 2 Diabetes Market Insights, Epidemiology, and Market Forecast 2030&#8221; report delivers an in-depth understanding of the historical and forecasted epidemiology as well as the Type 2 Diabetes market size and shares analysis in the 7MM (i.e the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan).<\/span><\/p>\n<p><strong>Healthcare Blogs By DelveInsight<\/strong><\/p>\n<ul>\n<li style=\"font-weight: 400;\"><a href=\"https:\/\/www.delveinsight.com\/blog\/leading-companies-in-autoimmune-diseases-market\/?utm_source=blog&amp;utm_medium=promotion&amp;utm_campaign=blog\"><strong>Companies in Autoimmune Diseases Market<\/strong><\/a><\/li>\n<li style=\"font-weight: 400;\"><a href=\"https:\/\/www.delveinsight.com\/blog\/insulin-delivery-devices-market\/?utm_source=blog&amp;utm_medium=promotion&amp;utm_campaign=blog\"><strong>Key Companies in Insulin Delivery Devices Market<\/strong><\/a><\/li>\n<li style=\"font-weight: 400;\"><a href=\"https:\/\/www.delveinsight.com\/blog\/femtech-market\/?utm_source=blog&amp;utm_medium=promotion&amp;utm_campaign=blog\"><strong>Companies in FemTech Market<\/strong><\/a><\/li>\n<li style=\"font-weight: 400;\"><a href=\"https:\/\/www.delveinsight.com\/blog\/skin-cancer-treatment-market-and-key-companies\/?utm_source=blog&amp;utm_medium=promotion&amp;utm_campaign=blog\"><strong>Common Types of Skin Cancers<\/strong><\/a><\/li>\n<li style=\"font-weight: 400;\"><a href=\"https:\/\/www.delveinsight.com\/blog\/cardiac-monitoring-devices-market\/?utm_source=blog&amp;utm_medium=promotion&amp;utm_campaign=blog\"><strong>Key Companies in Cardiac Monitoring Devices Market<\/strong><\/a><\/li>\n<li style=\"font-weight: 400;\"><a href=\"https:\/\/www.delveinsight.com\/blog\/jak-inhibitors-market\/?utm_source=blog&amp;utm_medium=promotion&amp;utm_campaign=blog\"><strong>JAK Inhibitors Companies&nbsp;<\/strong><\/a><\/li>\n<li style=\"font-weight: 400;\"><a href=\"https:\/\/www.delveinsight.com\/blog\/diabetic-macular-edema-therapy-market\/?utm_source=blog&amp;utm_medium=promotion&amp;utm_campaign=blog\"><strong>Diabetic Macular Edema Key Companies and Therapies<\/strong><\/a><\/li>\n<li style=\"font-weight: 400;\"><a href=\"https:\/\/www.delveinsight.com\/blog\/implantable-cardiac-monitors-market\/?utm_source=blog&amp;utm_medium=promotion&amp;utm_campaign=blog\"><strong>Implantable Cardiac Monitors Market Share<\/strong><\/a><\/li>\n<li style=\"font-weight: 400;\"><a href=\"https:\/\/www.delveinsight.com\/blog\/neurovascular-thrombectomy-devices-market\/?utm_source=blog&amp;utm_medium=promotion&amp;utm_campaign=blog\"><strong>Neurovascular Thrombectomy Devices Market Share<\/strong><\/a><\/li>\n<li style=\"font-weight: 400;\"><a href=\"https:\/\/www.delveinsight.com\/blog\/vagus-nerve-stimulator-market\/?utm_source=blog&amp;utm_medium=promotion&amp;utm_campaign=blog\"><strong>Vagus Nerve Stimulator Market Trends&nbsp;<\/strong><\/a><\/li>\n<li style=\"font-weight: 400;\"><a href=\"https:\/\/www.delveinsight.com\/blog\/pros-and-cons-of-wearable-devices\/?utm_source=blog&amp;utm_medium=promotion&amp;utm_campaign=blog\"><strong>Risk and Issue with Wearable Devices&nbsp;<\/strong><\/a><\/li>\n<li style=\"font-weight: 400;\"><a href=\"https:\/\/www.delveinsight.com\/blog\/age-related-hearing-loss-device-market\/?utm_source=blog&amp;utm_medium=promotion&amp;utm_campaign=blog\"><strong>Age-Related Hearing Loss Devices Market<\/strong><\/a><\/li>\n<li style=\"font-weight: 400;\"><a href=\"https:\/\/www.delveinsight.com\/blog\/technology-and-autism-spectrum-disorder\/?utm_source=blog&amp;utm_medium=promotion&amp;utm_campaign=blog\"><strong>Impact of Technology on People with Autism<\/strong><\/a><\/li>\n<li style=\"font-weight: 400;\"><a href=\"https:\/\/www.delveinsight.com\/blog\/eye-disorders-treatment-market\/?utm_source=blog&amp;utm_medium=promotion&amp;utm_campaign=blog\"><strong>Eye Disorders Treatment Market<\/strong><\/a><\/li>\n<li style=\"font-weight: 400;\"><a href=\"https:\/\/www.delveinsight.com\/blog\/transcranial-stimulation-devices-market\/\"><strong>Key Companies in the&nbsp; Transcranial Stimulation Devices Market&nbsp;<\/strong><\/a><\/li>\n<li style=\"font-weight: 400;\"><a href=\"https:\/\/www.delveinsight.com\/blog\/crohns-disease-market\/\"><strong>Key Companies in the Crohn&rsquo;s Disease Market&nbsp;<\/strong><\/a><\/li>\n<li style=\"font-weight: 400;\"><a href=\"https:\/\/www.delveinsight.com\/blog\/uncomplicated-urinary-tract-infections-market\/\"><strong>Treatment Options in the Uncomplicated Urinary Tract Infections Market<\/strong><\/a><\/li>\n<li style=\"font-weight: 400;\"><a href=\"https:\/\/www.delveinsight.com\/blog\/peanut-allergy-market\"><strong>Peanut Allergy Therapeutics Market<\/strong><\/a><\/li>\n<li style=\"font-weight: 400;\"><a href=\"https:\/\/www.delveinsight.com\/blog\/crohns-disease-market\/\"><strong>Crohn&rsquo;s Disease Therapeutic Market Growth<\/strong><\/a><\/li>\n<li style=\"font-weight: 400;\"><a href=\"https:\/\/www.delveinsight.com\/blog\/leading-companies-in-the-musculoskeletal-disorders-market\/\"><strong>Musculoskeletal Disorders Therapy Market<\/strong><\/a><\/li>\n<li style=\"font-weight: 400;\"><a href=\"https:\/\/www.delveinsight.com\/blog\/crohns-disease-market\/\"><strong>Key Companies in the Crohn&rsquo;s Disease Market<\/strong><\/a><\/li>\n<\/ul>\n<p><strong>About <\/strong><a href=\"https:\/\/www.delveinsight.com\/?utm_source=Icrowd&amp;utm_medium=pressrelease&amp;utm_campaign=rpr\"><strong>DelveInsight<\/strong><\/a><br \/><span style=\"font-weight: 400;\">DelveInsight is a leading Business Consultant and Market Research firm focused exclusively on life sciences. It supports Pharma companies by providing end-to-end comprehensive solutions to improve their performance.&nbsp; Get hassle-free access to all the healthcare and pharma market research reports through our subscription-based platform <\/span><a href=\"https:\/\/www.delveinsight.com\/pharmdelve?utm_source=Icrowd&amp;utm_medium=pressrelease&amp;utm_campaign=rpr\"><strong>PharmDelve<\/strong><\/a><span style=\"font-weight: 400;\">.<\/span><\/p>\n<p><strong>Connect With Us at <\/strong><a href=\"https:\/\/www.linkedin.com\/company\/delveinsight-business-research-llp\/\"><strong>LinkedIn<\/strong><\/a><strong> |<\/strong><a href=\"https:\/\/www.facebook.com\/delveinsightindia\/\"><strong> Facebook<\/strong><\/a><strong> |<\/strong><a href=\"https:\/\/twitter.com\/delve_insight\"><strong> Twitter<\/strong><\/a><\/p>\n<p class=\"tags\">Tags: <a href=\"https:\/\/icrowdnewswire.com\/tag\/covid-19-pipeline\/\" rel=\"tag\">COVID-19 Pipeline<\/a>, <a href=\"https:\/\/icrowdnewswire.com\/tag\/covid-19-drug-pipeline\/\" rel=\"tag\">COVID-19 Drug Pipeline<\/a>, <a href=\"https:\/\/icrowdnewswire.com\/tag\/covid-19\/\" rel=\"tag\">COVID-19<\/a>, <a href=\"https:\/\/icrowdnewswire.com\/tag\/covid-19-therapies\/\" rel=\"tag\">COVID-19 Therapies<\/a> <\/p>\n<div><strong>See Campaign: <\/strong><a href=\"https:\/\/www.delveinsight.com\/\" target=\"_blank\" rel=\"noopener noreferrer\">https:\/\/www.delveinsight.com\/<\/a><br \/><b>Contact Information:<\/b><br \/>Shruti Thakur\u00a0 info@delveinsight.com\u00a0 +1(919)321-6187\u00a0<\/p>\n<p><b>Tags:<\/b><br \/><a href=\"\"><\/a>, <a href=\"https:\/\/icrowdnewswire.com\/category\/pr-wirein\/\" rel=\"category tag\">PR-Wirein<\/a>, <a href=\"https:\/\/icrowdnewswire.com\/category\/menafn\/\" rel=\"category tag\">Menafn<\/a>, <a href=\"https:\/\/icrowdnewswire.com\/category\/ips\/\" rel=\"category tag\">IPS<\/a>, <a href=\"https:\/\/icrowdnewswire.com\/category\/reportedtimes\/\" rel=\"category tag\">Reportedtimes<\/a>, <a href=\"https:\/\/icrowdnewswire.com\/category\/news-category\/extended-distribution\/\" rel=\"category tag\">Extended Distribution<\/a>, <a href=\"https:\/\/icrowdnewswire.com\/category\/news-category\/icn-internal-distribution\/\" rel=\"category tag\">iCN Internal Distribution<\/a>, <a href=\"https:\/\/icrowdnewswire.com\/category\/news-category\/research-newswire\/\" rel=\"category tag\">Research Newswire<\/a>, <a href=\"https:\/\/icrowdnewswire.com\/category\/language\/english\/\" rel=\"category tag\">English<\/a><\/p>\n<p><img loading=\"lazy\" decoding=\"async\" src=\"\" alt=\"image\" width=\"400\" height=\"300\" class=\"cwdfimg\" \/><\/div>\n<div>\n<h3>Contact Information:<\/h3>\n<p>Shruti Thakur\u00a0 info@delveinsight.com\u00a0 +1(919)321-6187\u00a0<\/p>\n<\/p>\n<\/div>\n<p>The post <a rel=\"nofollow\" href=\"https:\/\/heymuse.com\/covid-19-vaccine-and-therapeutics-pipeline-analysis-key-companies-working-in-domain-includes-novavax-capricor-imv-abbvie-amgen-synairgen-maxwell-biosciences-veru-galera-sorrento-xenothera\/\">COVID-19 Vaccine and Therapeutics Pipeline Analysis | Key Companies Working in Domain Includes Novavax, Capricor, Imv, AbbVie, Amgen, Synairgen, Maxwell Biosciences, Veru, Galera, Sorrento, Xenothera, and Many Others<\/a> appeared first on <a rel=\"nofollow\" href=\"https:\/\/heymuse.com\">Financial Market Brief<\/a>.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>DelveInsight&rsquo;s COVID-19 Pipeline Insights report provides a comprehensive outlook of the pipeline therapies that are in different clinical and pre-clinical stages of development, their launch, and how the market is expected to transform in the aftermath across the COVID-19 domain. The COVID-19 Pipeline Analysis report offers an in-depth analysis of the therapeutics landscape by development [&hellip;]<\/p>\n<p>The post <a rel=\"nofollow\" href=\"https:\/\/heymuse.com\/covid-19-vaccine-and-therapeutics-pipeline-analysis-key-companies-working-in-domain-includes-novavax-capricor-imv-abbvie-amgen-synairgen-maxwell-biosciences-veru-galera-sorrento-xenothera\/\">COVID-19 Vaccine and Therapeutics Pipeline Analysis | Key Companies Working in Domain Includes Novavax, Capricor, Imv, AbbVie, Amgen, Synairgen, Maxwell Biosciences, Veru, Galera, Sorrento, Xenothera, and Many Others<\/a> appeared first on <a rel=\"nofollow\" href=\"https:\/\/heymuse.com\/\">Financial Market Brief<\/a>.<\/p>\n<p> <a href=\"https:\/\/ipsnews.net\/business\/2021\/08\/05\/covid-19-vaccine-and-therapeutics-pipeline-analysis-key-companies-working-in-domain-includes-novavax-capricor-imv-abbvie-amgen-synairgen-maxwell-biosciences-veru-galera-sorrento-xenothera\/\" class=\"more-link\">Continue Reading <span class=\"meta-nav\">&rarr;<\/span><\/a><\/p>\n","protected":false},"author":291,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[20],"tags":[],"class_list":["post-126427","post","type-post","status-publish","format-standard","hentry","category-press-release"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v24.9 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>COVID-19 Vaccine and Therapeutics Pipeline Analysis | Key Companies Working in Domain Includes Novavax, Capricor, Imv, AbbVie, Amgen, Synairgen, Maxwell Biosciences, Veru, Galera, Sorrento, Xenothera, and Many Others - Business<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"http:\/\/ipsnews.net\/business\/2021\/08\/05\/covid-19-vaccine-and-therapeutics-pipeline-analysis-key-companies-working-in-domain-includes-novavax-capricor-imv-abbvie-amgen-synairgen-maxwell-biosciences-veru-galera-sorrento-xenothera\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"COVID-19 Vaccine and Therapeutics Pipeline Analysis | Key Companies Working in Domain Includes Novavax, Capricor, Imv, AbbVie, Amgen, Synairgen, Maxwell Biosciences, Veru, Galera, Sorrento, Xenothera, and Many Others - Business\" \/>\n<meta property=\"og:description\" content=\"DelveInsight&rsquo;s COVID-19 Pipeline Insights report provides a comprehensive outlook of the pipeline therapies that are in different clinical and pre-clinical stages of development, their launch, and how the market is expected to transform in the aftermath across the COVID-19 domain. The COVID-19 Pipeline Analysis report offers an in-depth analysis of the therapeutics landscape by development [&hellip;] The post COVID-19 Vaccine and Therapeutics Pipeline Analysis | Key Companies Working in Domain Includes Novavax, Capricor, Imv, AbbVie, Amgen, Synairgen, Maxwell Biosciences, Veru, Galera, Sorrento, Xenothera, and Many Others appeared first on Financial Market Brief. Continue Reading &rarr;\" \/>\n<meta property=\"og:url\" content=\"http:\/\/ipsnews.net\/business\/2021\/08\/05\/covid-19-vaccine-and-therapeutics-pipeline-analysis-key-companies-working-in-domain-includes-novavax-capricor-imv-abbvie-amgen-synairgen-maxwell-biosciences-veru-galera-sorrento-xenothera\/\" \/>\n<meta property=\"og:site_name\" content=\"Business\" \/>\n<meta property=\"article:published_time\" content=\"2021-08-05T09:00:00+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/icrowdnewswire.com\/wp-content\/uploads\/2021\/05\/5353-Delveinsight.png\" \/>\n<meta name=\"author\" content=\"iCrowdNewswire\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"iCrowdNewswire\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"7 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"http:\/\/ipsnews.net\/business\/2021\/08\/05\/covid-19-vaccine-and-therapeutics-pipeline-analysis-key-companies-working-in-domain-includes-novavax-capricor-imv-abbvie-amgen-synairgen-maxwell-biosciences-veru-galera-sorrento-xenothera\/\",\"url\":\"http:\/\/ipsnews.net\/business\/2021\/08\/05\/covid-19-vaccine-and-therapeutics-pipeline-analysis-key-companies-working-in-domain-includes-novavax-capricor-imv-abbvie-amgen-synairgen-maxwell-biosciences-veru-galera-sorrento-xenothera\/\",\"name\":\"COVID-19 Vaccine and Therapeutics Pipeline Analysis | Key Companies Working in Domain Includes Novavax, Capricor, Imv, AbbVie, Amgen, Synairgen, Maxwell Biosciences, Veru, Galera, Sorrento, Xenothera, and Many Others - Business\",\"isPartOf\":{\"@id\":\"https:\/\/ipsnews.net\/business\/#website\"},\"primaryImageOfPage\":{\"@id\":\"http:\/\/ipsnews.net\/business\/2021\/08\/05\/covid-19-vaccine-and-therapeutics-pipeline-analysis-key-companies-working-in-domain-includes-novavax-capricor-imv-abbvie-amgen-synairgen-maxwell-biosciences-veru-galera-sorrento-xenothera\/#primaryimage\"},\"image\":{\"@id\":\"http:\/\/ipsnews.net\/business\/2021\/08\/05\/covid-19-vaccine-and-therapeutics-pipeline-analysis-key-companies-working-in-domain-includes-novavax-capricor-imv-abbvie-amgen-synairgen-maxwell-biosciences-veru-galera-sorrento-xenothera\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/icrowdnewswire.com\/wp-content\/uploads\/2021\/05\/5353-Delveinsight.png\",\"datePublished\":\"2021-08-05T09:00:00+00:00\",\"author\":{\"@id\":\"https:\/\/ipsnews.net\/business\/#\/schema\/person\/bde271d5882ffdcb71d1a2a961b51fee\"},\"breadcrumb\":{\"@id\":\"http:\/\/ipsnews.net\/business\/2021\/08\/05\/covid-19-vaccine-and-therapeutics-pipeline-analysis-key-companies-working-in-domain-includes-novavax-capricor-imv-abbvie-amgen-synairgen-maxwell-biosciences-veru-galera-sorrento-xenothera\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"http:\/\/ipsnews.net\/business\/2021\/08\/05\/covid-19-vaccine-and-therapeutics-pipeline-analysis-key-companies-working-in-domain-includes-novavax-capricor-imv-abbvie-amgen-synairgen-maxwell-biosciences-veru-galera-sorrento-xenothera\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"http:\/\/ipsnews.net\/business\/2021\/08\/05\/covid-19-vaccine-and-therapeutics-pipeline-analysis-key-companies-working-in-domain-includes-novavax-capricor-imv-abbvie-amgen-synairgen-maxwell-biosciences-veru-galera-sorrento-xenothera\/#primaryimage\",\"url\":\"https:\/\/icrowdnewswire.com\/wp-content\/uploads\/2021\/05\/5353-Delveinsight.png\",\"contentUrl\":\"https:\/\/icrowdnewswire.com\/wp-content\/uploads\/2021\/05\/5353-Delveinsight.png\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"http:\/\/ipsnews.net\/business\/2021\/08\/05\/covid-19-vaccine-and-therapeutics-pipeline-analysis-key-companies-working-in-domain-includes-novavax-capricor-imv-abbvie-amgen-synairgen-maxwell-biosciences-veru-galera-sorrento-xenothera\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/ipsnews.net\/business\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"COVID-19 Vaccine and Therapeutics Pipeline Analysis | Key Companies Working in Domain Includes Novavax, Capricor, Imv, AbbVie, Amgen, Synairgen, Maxwell Biosciences, Veru, Galera, Sorrento, Xenothera, and Many Others\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/ipsnews.net\/business\/#website\",\"url\":\"https:\/\/ipsnews.net\/business\/\",\"name\":\"Business\",\"description\":\"\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/ipsnews.net\/business\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\/\/ipsnews.net\/business\/#\/schema\/person\/bde271d5882ffdcb71d1a2a961b51fee\",\"name\":\"iCrowdNewswire\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/ipsnews.net\/business\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/aa079ec4d87ad6117c9db7a1a2cde1607ee2f869010252c2d0af346f0047b325?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/aa079ec4d87ad6117c9db7a1a2cde1607ee2f869010252c2d0af346f0047b325?s=96&d=mm&r=g\",\"caption\":\"iCrowdNewswire\"},\"sameAs\":[\"https:\/\/heymuse.com\/ips\"],\"url\":\"https:\/\/ipsnews.net\/business\/author\/icrowdnewswire\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"COVID-19 Vaccine and Therapeutics Pipeline Analysis | Key Companies Working in Domain Includes Novavax, Capricor, Imv, AbbVie, Amgen, Synairgen, Maxwell Biosciences, Veru, Galera, Sorrento, Xenothera, and Many Others - Business","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"http:\/\/ipsnews.net\/business\/2021\/08\/05\/covid-19-vaccine-and-therapeutics-pipeline-analysis-key-companies-working-in-domain-includes-novavax-capricor-imv-abbvie-amgen-synairgen-maxwell-biosciences-veru-galera-sorrento-xenothera\/","og_locale":"en_US","og_type":"article","og_title":"COVID-19 Vaccine and Therapeutics Pipeline Analysis | Key Companies Working in Domain Includes Novavax, Capricor, Imv, AbbVie, Amgen, Synairgen, Maxwell Biosciences, Veru, Galera, Sorrento, Xenothera, and Many Others - Business","og_description":"DelveInsight&rsquo;s COVID-19 Pipeline Insights report provides a comprehensive outlook of the pipeline therapies that are in different clinical and pre-clinical stages of development, their launch, and how the market is expected to transform in the aftermath across the COVID-19 domain. The COVID-19 Pipeline Analysis report offers an in-depth analysis of the therapeutics landscape by development [&hellip;] The post COVID-19 Vaccine and Therapeutics Pipeline Analysis | Key Companies Working in Domain Includes Novavax, Capricor, Imv, AbbVie, Amgen, Synairgen, Maxwell Biosciences, Veru, Galera, Sorrento, Xenothera, and Many Others appeared first on Financial Market Brief. Continue Reading &rarr;","og_url":"http:\/\/ipsnews.net\/business\/2021\/08\/05\/covid-19-vaccine-and-therapeutics-pipeline-analysis-key-companies-working-in-domain-includes-novavax-capricor-imv-abbvie-amgen-synairgen-maxwell-biosciences-veru-galera-sorrento-xenothera\/","og_site_name":"Business","article_published_time":"2021-08-05T09:00:00+00:00","og_image":[{"url":"https:\/\/icrowdnewswire.com\/wp-content\/uploads\/2021\/05\/5353-Delveinsight.png","type":"","width":"","height":""}],"author":"iCrowdNewswire","twitter_card":"summary_large_image","twitter_misc":{"Written by":"iCrowdNewswire","Est. reading time":"7 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"http:\/\/ipsnews.net\/business\/2021\/08\/05\/covid-19-vaccine-and-therapeutics-pipeline-analysis-key-companies-working-in-domain-includes-novavax-capricor-imv-abbvie-amgen-synairgen-maxwell-biosciences-veru-galera-sorrento-xenothera\/","url":"http:\/\/ipsnews.net\/business\/2021\/08\/05\/covid-19-vaccine-and-therapeutics-pipeline-analysis-key-companies-working-in-domain-includes-novavax-capricor-imv-abbvie-amgen-synairgen-maxwell-biosciences-veru-galera-sorrento-xenothera\/","name":"COVID-19 Vaccine and Therapeutics Pipeline Analysis | Key Companies Working in Domain Includes Novavax, Capricor, Imv, AbbVie, Amgen, Synairgen, Maxwell Biosciences, Veru, Galera, Sorrento, Xenothera, and Many Others - Business","isPartOf":{"@id":"https:\/\/ipsnews.net\/business\/#website"},"primaryImageOfPage":{"@id":"http:\/\/ipsnews.net\/business\/2021\/08\/05\/covid-19-vaccine-and-therapeutics-pipeline-analysis-key-companies-working-in-domain-includes-novavax-capricor-imv-abbvie-amgen-synairgen-maxwell-biosciences-veru-galera-sorrento-xenothera\/#primaryimage"},"image":{"@id":"http:\/\/ipsnews.net\/business\/2021\/08\/05\/covid-19-vaccine-and-therapeutics-pipeline-analysis-key-companies-working-in-domain-includes-novavax-capricor-imv-abbvie-amgen-synairgen-maxwell-biosciences-veru-galera-sorrento-xenothera\/#primaryimage"},"thumbnailUrl":"https:\/\/icrowdnewswire.com\/wp-content\/uploads\/2021\/05\/5353-Delveinsight.png","datePublished":"2021-08-05T09:00:00+00:00","author":{"@id":"https:\/\/ipsnews.net\/business\/#\/schema\/person\/bde271d5882ffdcb71d1a2a961b51fee"},"breadcrumb":{"@id":"http:\/\/ipsnews.net\/business\/2021\/08\/05\/covid-19-vaccine-and-therapeutics-pipeline-analysis-key-companies-working-in-domain-includes-novavax-capricor-imv-abbvie-amgen-synairgen-maxwell-biosciences-veru-galera-sorrento-xenothera\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["http:\/\/ipsnews.net\/business\/2021\/08\/05\/covid-19-vaccine-and-therapeutics-pipeline-analysis-key-companies-working-in-domain-includes-novavax-capricor-imv-abbvie-amgen-synairgen-maxwell-biosciences-veru-galera-sorrento-xenothera\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"http:\/\/ipsnews.net\/business\/2021\/08\/05\/covid-19-vaccine-and-therapeutics-pipeline-analysis-key-companies-working-in-domain-includes-novavax-capricor-imv-abbvie-amgen-synairgen-maxwell-biosciences-veru-galera-sorrento-xenothera\/#primaryimage","url":"https:\/\/icrowdnewswire.com\/wp-content\/uploads\/2021\/05\/5353-Delveinsight.png","contentUrl":"https:\/\/icrowdnewswire.com\/wp-content\/uploads\/2021\/05\/5353-Delveinsight.png"},{"@type":"BreadcrumbList","@id":"http:\/\/ipsnews.net\/business\/2021\/08\/05\/covid-19-vaccine-and-therapeutics-pipeline-analysis-key-companies-working-in-domain-includes-novavax-capricor-imv-abbvie-amgen-synairgen-maxwell-biosciences-veru-galera-sorrento-xenothera\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/ipsnews.net\/business\/"},{"@type":"ListItem","position":2,"name":"COVID-19 Vaccine and Therapeutics Pipeline Analysis | Key Companies Working in Domain Includes Novavax, Capricor, Imv, AbbVie, Amgen, Synairgen, Maxwell Biosciences, Veru, Galera, Sorrento, Xenothera, and Many Others"}]},{"@type":"WebSite","@id":"https:\/\/ipsnews.net\/business\/#website","url":"https:\/\/ipsnews.net\/business\/","name":"Business","description":"","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/ipsnews.net\/business\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/ipsnews.net\/business\/#\/schema\/person\/bde271d5882ffdcb71d1a2a961b51fee","name":"iCrowdNewswire","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/ipsnews.net\/business\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/aa079ec4d87ad6117c9db7a1a2cde1607ee2f869010252c2d0af346f0047b325?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/aa079ec4d87ad6117c9db7a1a2cde1607ee2f869010252c2d0af346f0047b325?s=96&d=mm&r=g","caption":"iCrowdNewswire"},"sameAs":["https:\/\/heymuse.com\/ips"],"url":"https:\/\/ipsnews.net\/business\/author\/icrowdnewswire\/"}]}},"amp_enabled":true,"_links":{"self":[{"href":"https:\/\/ipsnews.net\/business\/wp-json\/wp\/v2\/posts\/126427","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/ipsnews.net\/business\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/ipsnews.net\/business\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/ipsnews.net\/business\/wp-json\/wp\/v2\/users\/291"}],"replies":[{"embeddable":true,"href":"https:\/\/ipsnews.net\/business\/wp-json\/wp\/v2\/comments?post=126427"}],"version-history":[{"count":1,"href":"https:\/\/ipsnews.net\/business\/wp-json\/wp\/v2\/posts\/126427\/revisions"}],"predecessor-version":[{"id":126428,"href":"https:\/\/ipsnews.net\/business\/wp-json\/wp\/v2\/posts\/126427\/revisions\/126428"}],"wp:attachment":[{"href":"https:\/\/ipsnews.net\/business\/wp-json\/wp\/v2\/media?parent=126427"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/ipsnews.net\/business\/wp-json\/wp\/v2\/categories?post=126427"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/ipsnews.net\/business\/wp-json\/wp\/v2\/tags?post=126427"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}